BioAtla (BCAB) Cash from Financing Activities (2020 - 2026)

BioAtla's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $110000.0 for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 127.85% year-over-year to $110000.0 in Q1 2026; TTM through Mar 2026 was $6.8 million, a 25.72% decrease from a year earlier, with the FY2025 full-year figure at $6.3 million, down 34.01% from the prior year.
• Cash from Financing Activities slipped to $110000.0 in Q1 2026 per BCAB's latest filing, from $6.7 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $61.8 million in Q4 2022 and bottomed at -$405000.0 in Q1 2022.
• The 5-year median for Cash from Financing Activities is -$13000.0 (2024), against an average of $4.5 million.
• Across the five-year window, Cash from Financing Activities jumped 7726.05% in 2024 and sank 2938.46% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $61.8 million in 2022, then sank by 99.81% to $119000.0 in 2023, then soared by 7726.05% to $9.3 million in 2024, then declined by 27.92% to $6.7 million in 2025, then tumbled by 98.36% to $110000.0 in 2026.
• Per Business Quant, the three latest BCAB Cash from Financing Activities figures stand at $110000.0 (Q1 2026), $6.7 million (Q4 2025), and -$6000.0 (Q3 2025).